Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
11
×
Tags
cancer
11
×
boston blog main
life sciences
national blog main
biotech
boston top stories
san francisco blog main
clinical trials
national top stories
san francisco top stories
cancer drugs
europe blog main
indiana blog main
indiana top stories
amgen
blueprint medicines
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
europe top stories
national
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
avapritinib
boston
What
drug
11
×
cancer
new
medicine
research
fda
medicines
patients
approval
bio
blueprint
cells
designed
effective
fight
ipo
market
roundup
study
targets
treatment
tumors
type
acquisitions
actually
address
advantages
aggressive
aid
announced
anti
antibodies
approves
bad
bar
biggest
biotech
black
brings
build
Language
unset
11
×
Current search:
drug
×
unset
×
photo
×
cancer
×
@bgr.com
1 year ago
Nano-robot antibodies that fight cancer enter first human drug trial
@bgr.com
1 year ago
Doctors may have found a secret weapon to fight cancer: Viagra
@bgr.com
3 years ago
A drug for diarrhea can kill aggressive cancer cells
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@geekwire.com
4 years ago
Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug